Can you share a case where topical therapies have failed to produce an acceptable clinical response, and in whom consideration of immunotherapy—including systemic treatment with dupilumab—would be indicated?

Can you share a case where topical therapies have failed to produce an acceptable clinical response, and in whom consideration of immunotherapy—including systemic treatment with dupilumab—would be indicated?

Can you share a case where topical therapies have failed to produce an acceptable clinical response, and in whom consideration of immunotherapy—including systemic treatment with dupilumab—would be indicated? 


Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Peter Lio, MD

Peter Lio, MD

Clinical Assistant Professor of Dermatology and Pediatrics
Feinberg School of Medicine
Northwestern University
Chicago, Illinois